anti-infectives
Offering innovation and hope in the treatment of infectious diseases requires specialization and commitment.

Established as leader in transplantation and urology, Astellas also focuses its experience and technical capacity in the development of Anti-infective agents.

Astellas actively participates in the research and development of advanced therapies for fungal and bacterial infections. We will continue our commitment in this field as we strive to offer pioneering treatments aimed at the evolving needs of this complex area

EN_PIL Mycamine

Learn more about our therapeutic areas:

Oncology

Through research programs, we aim to change the tomorrow of patients suffering from solid tumours, such as Prostate Cancer, and haematologic malignancies.

Urology

Focused on research to meet the needs in Benign Prostatic Hyperplasia (BPH) and Overactive Bladder Syndrome (OAB).

Transplantation

Innovative therapies for the prevention and treatment of organ rejection

Anti-infectives

We tackle the complex challenges of Fungal and Bacterial Infections

NON_2019_0011_GR

Innovation

RELATED LINKS

R & D

Research and Development is at the core of everything we do. It not only drives our work today, but it fosters the work we will do tomorrow...

Read More